Skip to content
The Policy VaultThe Policy Vault

biologic immunomodulator agentsBlue Cross Blue Shield of Oklahoma

posterior uveitis

Initial criteria

  • Has tried and had an inadequate response to ONE oral or periocular/intravitreal corticosteroid injection after at least a 2-week duration OR intolerance/hypersensitivity OR contraindication to all corticosteroids AND
  • Has tried and had an inadequate response to ONE conventional systemic agent (azathioprine, mycophenolate, methotrexate, cyclosporine, tacrolimus) after at least a 3-month duration OR intolerance/hypersensitivity OR contraindication to all conventional systemic agents OR patient has severe, active, sight-threatening disease OR medication history shows another biologic immunomodulator used for this indication